Draft:Management of irritable bowel syndrome
![]() | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by IntentionallyDense (talk | contribs) 15 minutes ago. (Update) |
Lifestyle
[edit]According to NICE guidelines, those with IBS should receive information regarding the significance of self-help, such as lifestyle, physical activity, diet, and symptom management, in managing IBS. NICE guidelines recommend that healthcare professionals encourage those with IBS to make the most of their leisure time and take time to relax. NICE guidelines also recommend assessing the physical activity levels of those with IBS; healthcare professionals are advised to give advice and counselling to those with low activity levels.[1]
Lifestyle habits such as diet, sleep, exercise, and other behaviours can all play in role in IBS symptoms. Exercise such as yoga, aerobics, and walking can help manage the symptoms of IBS.[2][3]
Dietary
[edit]At least 80% of those with IBS have food-related symptoms. Those who have food-related symptoms tend to experience more severe symptoms.[4] Many people with IBS are therefore willing to make dietary modifications.[5] There are many mechanisms in which food can trigger IBS symptoms such as osmotic, immunological, chemical, mechanical or neuroendocrine effects and fermentation by-products, alterations in intraluminal pH or effects on the gut microbiome.[6][5]
General advice for diet in those with IBS includes eating regular meals, taking time to eat, avoiding missing meals or large gaps between eating, reducing the consumption of fat, limiting the consumption of fizzy drinks and alcohol, avoiding spicy foods, restricting caffeinated beverages to 3 cups per day, and drinking at least 8 cups of fluid a day.[1][7]
Fibre
[edit]Dietary fibre is a carbohydrate that is not digested through the small intestine and has a polymerization degree of three or more monomeric units. The US Food and Drug Administration recommends 25–35 grams of fiber per day.[8] NICE guidelines recommend that healthcare professionals review the intake of fibre for those with IBS and make adjustments while monitoring symptoms.[9][7] Insoluble fibre is often discouraged for those with IBS, as it can worsen symptoms, while soluble fibre is recommended.[10][11] Insoluble fibre is found in wheat bran, whole grains, and fruit and vegetable skins and seeds.[12] Soluble fibre is found in psyllium, oat bran, barley, and beans.[8]
FODMAP
[edit]NICE guidelines recommend that if a person does not respond to general lifestyle and diet advice a low FODMAP diet (LDF) should be implemented with the help of a healthcare professional who has education in dietary management.[9]
Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are poorly absorbed short-chain carbohydrates that cause bacterial fermentation to release gases, primarily hydrogen and carbon dioxide, and increase the water content of the small intestine by osmosis.[13] A LFD is introduced in multiple stages. The first phase typically lasts 4-8 weeks and involves cutting out all FODMAP foods. The following phase, which lasts six to ten weeks, is introduced if people's symptoms improve. With the reintroduction of FODMAPs, individuals are able to identify the specific FODMAP triggers that cause their symptoms. Individuals then move on to the long-term personalization phase, during which they consume a less restrictive diet and just avoid FODMAPs that cause symptoms.[14][15]
Probiotics
[edit]Probiotics can be helpful in treating symptoms of IBS however there is not enough evidence that specific strains are more effective than others.[16][17] The British Society of Gastroenterology and Canadian Association of Gastroenterology guidelines both recommend that people who choose to take probiotics should do so for a limited amount of time and stop them if they do not improve symptoms.[10][18] NICE guidelines recommend that people should take probiotics according to the manufacturer's recommended dosage.[9]
Pharmacological
[edit]Psychological
[edit]NICE guidelines recommend that people with IBS who don’t respond to IBS medication after a year and continue to develop symptoms, known as refractory IBS, should try psychological interventions such as cognitive behavioural therapy (CBT), hypnotherapy, or other psychological interventions.[19]
CBT and hypnotherapy have both been found to be effective in managing IBS.[20] CBT can be administered over the phone, face-to-face, or in a group setting.[21][22] These therapies incorporate a variety of skills-based methods, including exposure, behavioural experiments with avoiding symptoms or situations where they occur, cognitive reframing of negative ideas, relaxation training, and reducing helplessness. They can also involve methods that change how pain is perceived by stimulating brain regions that reduce gut sensations and boost psychological adaptability, acceptance, and self-efficacy.[23] Multicomponent psychological treatment and in-person dynamic psychotherapy can be helpful interventions. However, there is a lack of evidence on these kinds of psychological interventions.[22]
Complementary and alternative
[edit]References
[edit]Citations
[edit]- ^ a b NICE 2008, p. 13.
- ^ Okawa 2022, pp. 3–4.
- ^ Chamera-Cyrek et al. 2024, p. 4.
- ^ Böhn et al. 2013, p. 637.
- ^ a b Vasant et al. 2021, p. 1226.
- ^ Moayyedi, Simrén & Bercik 2020, pp. 407–408.
- ^ a b Rej et al. 2022, p. 2.
- ^ a b Chey et al. 2022, p. 1740.
- ^ a b c NICE 2008, p. 14.
- ^ a b Vasant et al. 2021, p. 1227.
- ^ Moayyedi et al. 2019, p. 15.
- ^ Lacy et al. 2020, p. 29.
- ^ Hill, Muir & Gibson 2017, p. 37.
- ^ Whelan et al. 2018, pp. 245, 246, 249, 250.
- ^ Rej et al. 2022, p. 4.
- ^ Jia et al. 2020, p. 73.
- ^ Goodoory et al. 2023, p. 1214.
- ^ Moayyedi et al. 2019, p. 17.
- ^ NICE 2008, p. 16.
- ^ Moayyedi et al. 2019, p. 19.
- ^ Vasant et al. 2021, p. 1231.
- ^ a b Black et al. 2020, p. 1449.
- ^ Lacy et al. 2020, p. 37.
Sources
[edit]- "Irritable bowel syndrome in adults: diagnosis and management". NICE. 2008-02-23. Retrieved 2024-10-20.
- Okawa, Yohei (2022-10-12). "A Discussion of Whether Various Lifestyle Changes can Alleviate the Symptoms of Irritable Bowel Syndrome". Healthcare. 10 (10). MDPI AG: 2011. doi:10.3390/healthcare10102011. ISSN 2227-9032. PMC 9602372. PMID 36292457.
- Chamera-Cyrek, Katarzyna; Sikora, Oliwia; Baran, Jan; Rowiński, Dawid; Kuzminski, Clara; Podczerwińska, Aneta; Prokop, Dominika; Borek, Mikołaj; Kamil Marzec, Kamil Bartlomiej; Jabloński, Wiktor; Kupczak, Wojciech (2024-09-03). "The Role of Lifestyle-Related Treatments for Irritable Bowel Syndrome". Archiv Euromedica. 14 (4). European Scientific Society. doi:10.35630/2024/14/4.410. ISSN 2199-885X.
- Böhn, Lena; Störsrud, Stine; Törnblom, Hans; Bengtsson, Ulf; Simrén, Magnus (2013). "Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life". American Journal of Gastroenterology. 108 (5). Ovid Technologies (Wolters Kluwer Health): 634–641. doi:10.1038/ajg.2013.105. ISSN 0002-9270. PMID 23644955.
- Moayyedi, Paul; Simrén, Magnus; Bercik, Premysl (2020-03-02). "Evidence-based and mechanistic insights into exclusion diets for IBS". Nature Reviews Gastroenterology & Hepatology. 17 (7). Springer Science and Business Media LLC: 406–413. doi:10.1038/s41575-020-0270-3. ISSN 1759-5045. PMID 32123377.
- Vasant, Dipesh H; Paine, Peter A; Black, Christopher J; Houghton, Lesley A; Everitt, Hazel A; Corsetti, Maura; Agrawal, Anurag; Aziz, Imran; Farmer, Adam D; Eugenicos, Maria P; Moss-Morris, Rona; Yiannakou, Yan; Ford, Alexander C (2021-04-26). "British Society of Gastroenterology guidelines on the management of irritable bowel syndrome". Gut. 70 (7). BMJ: 1214–1240. doi:10.1136/gutjnl-2021-324598. ISSN 0017-5749. PMID 33903147.
- Rej, A.; Avery, A.; Aziz, I.; Black, C. J.; Bowyer, R. K.; Buckle, R. L.; Seamark, L.; Shaw, C. C.; Thompson, J.; Trott, N.; Williams, M.; Sanders, D. S. (2022-09-13). "Diet and irritable bowel syndrome: an update from a UK consensus meeting". BMC Medicine. 20 (1). Springer Science and Business Media LLC. doi:10.1186/s12916-022-02496-w. ISSN 1741-7015.
- Lacy, Brian E.; Pimentel, Mark; Brenner, Darren M.; Chey, William D.; Keefer, Laurie A.; Long, Millie D.; Moshiree, Baha (2020-12-14). "ACG Clinical Guideline: Management of Irritable Bowel Syndrome". American Journal of Gastroenterology. 116 (1). Ovid Technologies (Wolters Kluwer Health): 17–44. doi:10.14309/ajg.0000000000001036. ISSN 0002-9270.
- Chey, William D.; Hashash, Jana G.; Manning, Laura; Chang, Lin (2022). "AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review". Gastroenterology. 162 (6). Elsevier BV: 1737–1745.e5. doi:10.1053/j.gastro.2021.12.248. ISSN 0016-5085. PMID 35337654.
- Hill, Peta; Muir, Jane G.; Gibson, Peter R. (2017). "Controversies and Recent Developments of the Low-FODMAP Diet". Gastroenterology & Hepatology. 13 (1): 36–45. ISSN 1554-7914. PMC 5390324. PMID 28420945.
- Whelan, K.; Martin, L. D.; Staudacher, H. M.; Lomer, M. C. E. (2018-01-15). "The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice". Journal of Human Nutrition and Dietetics. 31 (2). Wiley: 239–255. doi:10.1111/jhn.12530. ISSN 0952-3871. PMID 29336079.
- Moayyedi, Paul; Andrews, Christopher N; MacQueen, Glenda; Korownyk, Christina; Marsiglio, Megan; Graff, Lesley; Kvern, Brent; Lazarescu, Adriana; Liu, Louis; Paterson, William G; Sidani, Sacha; Vanner, Stephen (2019-01-17). "Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)". Journal of the Canadian Association of Gastroenterology. 2 (1). Oxford University Press (OUP): 6–29. doi:10.1093/jcag/gwy071. ISSN 2515-2084. PMC 6507291. PMID 31294724.
- Jia, Li-Qun; Sun, Jian-Rong; Kong, Chen-Fan; Qu, Xiang-Ke; Deng, Chao; Lou, Yan-Ni (2020). "Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis". Saudi Journal of Gastroenterology. 26 (2). Medknow: 66–77. doi:10.4103/sjg.sjg_384_19. ISSN 1319-3767. PMC 7279071. PMID 31898645.
- Goodoory, Vivek C.; Khasawneh, Mais; Black, Christopher J.; Quigley, Eamonn M.M.; Moayyedi, Paul; Ford, Alexander C. (2023). "Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis". Gastroenterology. 165 (5). Elsevier BV: 1206–1218. doi:10.1053/j.gastro.2023.07.018. ISSN 0016-5085. PMID 37541528.
- Black, Christopher J; Thakur, Elyse R; Houghton, Lesley A; Quigley, Eamonn M M; Moayyedi, Paul; Ford, Alexander C (2020-04-10). "Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis". Gut. 69 (8). BMJ: 1441–1451. doi:10.1136/gutjnl-2020-321191. ISSN 0017-5749. PMID 32276950.